Table 3.
Secondary outcomes: handgrip strength, body mass index, and absolute lymphocyte count among the curcumin and placebo group patients, as an average change and percentage of an average change.
| Group | Handgrip strength, kg (mean ± SD) | Body mass index (mean ± SD) | Absolute lymphocyte count, cell/mm3 (mean ± SD) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 0 | Week 8 | Mean change (95% CI) | % Change (95% CI) | Week 0 | Week 8 | Mean change (95% CI) | % Change (95% CI) | Week 0 | Week 8 | Mean change (95% CI) | % Change (95% CI) | |
| Curcumin | 26.24 ± 4.69 | 26.85 ± 6.18 | 0.61 (−2.17, 3.39) | 2.73 (−9.62, 15.07) | 18.49 ± 2.2 | 18.38 ± 2.47 | −0.1 (−0.71, 0.51) | −0.63 (−4.1, 2.84) | 1017.6 ± 693.4 | 789.9 ± 547.61 | −227.7 (−694.7, 239.3) | −4.55 (−45.78, 36.69) |
| Placebo | 26.19 ± 8.48 | 25.57 ± 8.24 | −0.62 (−3.03, 1.79) | −0.82 (−10.16, 8.52) | 19.53 ± 2.86 | 18.65 ± 2.47 | −0.88 (−1.85, 0.08) | −4.2 (−8.64, 0.25) | 1495 ± 756.88 | 606.1 ± 191.89 | −888.9 (−1439.45, −338.35) | −48.31 (−68.62, −28) |
| p values | 0.956 | 0.935 | 0.206 | 0.344 | 0.053 | 0.05 | ||||||